GH - Guardant Health, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Redwood City,
United States
Type: Equity
GH price evolution
GH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1133.54 | $457.34 | $271.07 | $223.64 |
| Short term investments | $35.1 | $697.48 | $953.78 | $713.38 |
| Net receivables | $88.78 | $88.8 | $86.47 | $87.2 |
| Inventory | $61.95 | $77.04 | $60.53 | $46.47 |
| Total current assets | $1347.11 | $1346.9 | $1397.65 | $1104.46 |
| Long term investments | ||||
| Property, plant & equipment | $302.71 | $309.34 | $321.01 | $333.88 |
| Goodwill & intangible assets | $12.27 | $12.96 | $13.65 | $14.34 |
| Total noncurrent assets | $439.31 | $450.33 | $442.36 | $407.17 |
| Total investments | $35.1 | $697.48 | $953.78 | $713.38 |
| Total assets | $1786.42 | $1797.23 | $1840.02 | $1511.63 |
| Current liabilities | ||||
| Accounts payable | $187.95 | $205.27 | $188.7 | $190.53 |
| Deferred revenue | $17.96 | $21.48 | $12.24 | $13.62 |
| Short long term debt | ||||
| Total current liabilities | $205.92 | $226.75 | $200.93 | $204.16 |
| Long term debt | $1325.81 | $1332 | $1336.91 | $1342.89 |
| Total noncurrent liabilities | $1421.82 | $1342.18 | $1346.36 | $1352.03 |
| Total debt | $1325.81 | $1332 | $1336.91 | $1342.89 |
| Total liabilities | $1627.74 | $1568.93 | $1547.29 | $1556.18 |
| Shareholders' equity | ||||
| Retained earnings | -$2141.86 | -$1954.82 | -$1868.72 | -$1795.95 |
| Other shareholder equity | -$3.67 | -$5.68 | -$8.47 | -$12.15 |
| Total shareholder equity | $158.68 | $228.3 | $292.73 | -$44.55 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1133.54 | $141.65 | $492.2 | $832.98 |
| Short term investments | $35.1 | $869.58 | $440.55 | $961.9 |
| Net receivables | $88.78 | $97.26 | $97.65 | $53.3 |
| Inventory | $61.95 | $51.6 | $30.67 | $22.72 |
| Total current assets | $1347.11 | $1191.59 | $1114.13 | $1888.36 |
| Long term investments | $698.03 | $246.6 | ||
| Property, plant & equipment | $302.71 | $341.92 | $313.9 | $100.13 |
| Goodwill & intangible assets | $12.27 | $15.02 | $17.5 | $19.49 |
| Total noncurrent assets | $439.31 | $418.39 | $1090.37 | $383.42 |
| Total investments | $35.1 | $869.58 | $1138.58 | $1208.5 |
| Total assets | $1786.42 | $1609.98 | $2204.5 | $2271.78 |
| Current liabilities | ||||
| Accounts payable | $187.95 | $68.91 | $17.58 | $7.34 |
| Deferred revenue | $17.96 | $17.4 | $11.33 | $8.55 |
| Short long term debt | ||||
| Total current liabilities | $205.92 | $193.22 | $194.69 | $66.81 |
| Long term debt | $1325.81 | $1137.39 | $1360.87 | $847.86 |
| Total noncurrent liabilities | $1421.82 | $1356.59 | $1364.81 | $849.38 |
| Total debt | $1325.81 | $1347.41 | $1360.87 | $847.86 |
| Total liabilities | $1627.74 | $1549.81 | $1559.49 | $916.19 |
| Shareholders' equity | ||||
| Retained earnings | -$2141.86 | -$1662.41 | -$1007.83 | -$606.59 |
| Other shareholder equity | -$3.67 | -$19.52 | -$4.76 | $2.7 |
| Total shareholder equity | $158.68 | $60.18 | $645 | $1298.49 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $155.05 | $143.03 | $137.15 | $128.71 |
| Cost of revenue | $62.52 | $57.61 | $53.85 | $53.07 |
| Gross Profit | $92.54 | $85.42 | $83.3 | $75.64 |
| Operating activities | ||||
| Research & development | $89.86 | $93.85 | $90.36 | $93.13 |
| Selling, general & administrative | $116.79 | $105.11 | $112.56 | $116.57 |
| Total operating expenses | $290.05 | $198.96 | $202.92 | $209.7 |
| Operating income | -$197.51 | -$113.54 | -$119.62 | -$134.06 |
| Income from continuing operations | ||||
| EBIT | -$186.94 | -$84.97 | -$71.63 | -$132.65 |
| Income tax expense | -$0.54 | $0.49 | $0.5 | $0.24 |
| Interest expense | $0.65 | $0.64 | $0.65 | $0.64 |
| Net income | ||||
| Net income | -$187.04 | -$86.1 | -$72.77 | -$133.53 |
| Income (for common shares) | -$187.04 | -$86.1 | -$72.77 | -$133.53 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $563.95 | $449.54 | $373.65 | $286.73 |
| Cost of revenue | $227.05 | $156.32 | $122.91 | $92.53 |
| Gross Profit | $336.9 | $293.21 | $250.74 | $194.19 |
| Operating activities | ||||
| Research & development | $367.19 | $373.81 | $263.22 | $149.86 |
| Selling, general & administrative | $451.03 | $463.78 | $398.52 | $299.28 |
| Total operating expenses | $901.62 | $837.59 | $661.74 | $449.14 |
| Operating income | -$564.73 | -$544.38 | -$411 | -$254.95 |
| Income from continuing operations | ||||
| EBIT | -$476.19 | -$650.87 | -$402.79 | -$248.64 |
| Income tax expense | $0.69 | $1.14 | $0.3 | $0.38 |
| Interest expense | $2.58 | $2.58 | $2.58 | $4.77 |
| Net income | ||||
| Net income | -$479.45 | -$654.59 | -$405.67 | -$253.78 |
| Income (for common shares) | -$479.45 | -$654.59 | -$405.67 | -$253.78 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$187.04 | -$86.1 | -$72.77 | -$133.53 |
| Operating activities | ||||
| Depreciation | $10.87 | $11.04 | $10.63 | $10.35 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $24.32 | $21.82 | $22.35 | $22.27 |
| Total cash flows from operations | -$78.73 | -$77.79 | -$94.02 | -$74.44 |
| Investing activities | ||||
| Capital expenditures | -$4.08 | -$2.37 | -$6.51 | -$7.52 |
| Investments | $666 | $263.07 | -$234.61 | $164.75 |
| Total cash flows from investing | $663.45 | $260.7 | -$241.13 | $157.22 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $114.67 | $0.86 | $387.99 | $0.16 |
| Net borrowings | $0.04 | -$0.02 | -$0.02 | |
| Total cash flows from financing | $90.57 | $3.81 | $383.85 | -$0.85 |
| Effect of exchange rate | $1.03 | -$0.53 | -$1.25 | -$0.16 |
| Change in cash and equivalents | $676.32 | $186.19 | $47.46 | $81.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$479.45 | -$654.59 | -$405.67 | -$253.78 |
| Operating activities | ||||
| Depreciation | $42.88 | $64.55 | $46.93 | $21.63 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $90.76 | $94.69 | $151.45 | $144.11 |
| Total cash flows from operations | -$324.98 | -$309.46 | -$209.02 | -$103.93 |
| Investing activities | ||||
| Capital expenditures | -$20.49 | -$77.46 | -$75.03 | -$54.06 |
| Investments | $859.21 | $227.28 | $11.88 | -$563.03 |
| Total cash flows from investing | $840.25 | $149.82 | -$63.16 | -$617.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $503.68 | $11.94 | $17.86 | $371.22 |
| Net borrowings | -$0.07 | -$0.93 | $1132.58 | |
| Total cash flows from financing | $477.38 | -$189.09 | -$66.82 | $1410.31 |
| Effect of exchange rate | -$0.91 | -$1.6 | -$1.69 | $0.46 |
| Change in cash and equivalents | $991.74 | -$350.34 | -$340.69 | $689.75 |
News
Fundamentals
| Market cap | $2.20B |
|---|---|
| Enterprise value | $2.39B |
| Shares outstanding | 121.63M |
| Revenue | $563.95M |
|---|---|
| EBITDA | -$433.31M |
| EBIT | -$476.19M |
| Net Income | -$479.45M |
| Revenue Q/Q | 22.19% |
| Revenue Y/Y | 25.45% |
| P/E ratio | -4.59 |
|---|---|
| EV/Sales | 4.24 |
| EV/EBITDA | -5.52 |
| EV/EBIT | -5.03 |
| P/S ratio | 3.90 |
| P/B ratio | 13.56 |
| Book/Share | 1.33 |
| Cash/Share | 9.32 |
| EPS | -$3.94 |
|---|---|
| ROA | -27.65% |
| ROE | -301.94% |
| Debt/Equity | 10.26 |
|---|---|
| Net debt/EBITDA | -1.14 |
| Current ratio | 6.54 |
| Quick ratio | 6.24 |